What Is Wellbutrin SR? Uses, Dosage, and Side Effects

Wellbutrin SR is the sustained-release form of bupropion, an antidepressant that works differently from the SSRIs most people associate with depression treatment. Instead of targeting serotonin, bupropion blocks the reuptake of two other brain chemicals, norepinephrine and dopamine, which gives it a distinct side-effect profile that many people find preferable. The “SR” in the name refers to how the tablet releases medication over about 12 hours, which means you take it twice a day rather than three times (as with the older immediate-release version) or once (as with the XL version).

How Bupropion Works

Most popular antidepressants fall into the SSRI category, meaning they increase serotonin levels in the brain. Bupropion does something fundamentally different. It inhibits the reuptake of both norepinephrine and dopamine without any meaningful effect on serotonin or on postsynaptic receptors.¹ That distinction matters because many of the side effects people dread from antidepressants, particularly sexual dysfunction and weight gain, are tied to serotonin pathways. By leaving serotonin alone, bupropion sidesteps those issues for most users.

The dopamine component also helps explain why bupropion is effective for smoking cessation. Nicotine triggers dopamine release, and when you quit smoking, the sudden drop in dopamine contributes to withdrawal symptoms like low mood and difficulty concentrating. Bupropion partially compensates for that drop. It also appears to block nicotinic acetylcholine receptors, which may reduce the rewarding feeling of smoking if you do relapse.²

What Wellbutrin SR Is Approved For

Bupropion has two FDA-approved indications: major depressive disorder and smoking cessation (when marketed under the brand name Zyban). For depression, the sustained-release formulation has been shown to significantly reduce the risk of relapse compared to placebo, with the separation between drug and placebo becoming clear after several weeks of continued treatment.³

For smoking cessation, the numbers are encouraging if not dramatic. Across clinical trials, bupropion helps roughly one in five smokers quit successfully, which is a meaningful improvement over placebo.⁴ The effect seems to work primarily by easing withdrawal symptoms rather than by blocking the nicotine high in real time.²

Beyond those two approved uses, bupropion is also prescribed off-label for ADHD in adults, particularly when first-line stimulant medications are not tolerated or when a patient has a history of substance misuse that makes stimulant prescribing risky.⁵ Its dopamine and norepinephrine activity gives it a mild stimulant-like quality that can improve focus and motivation without the abuse potential that comes with traditional stimulants.

SR Versus XL Versus Immediate Release

One of the most common points of confusion is the difference between bupropion’s three formulations. All three deliver the same active ingredient and are bioequivalent in terms of total drug exposure over the course of a day.⁶ The difference is in how quickly the drug peaks in your bloodstream and how often you take it:

Immediate release (Wellbutrin): taken three times daily, peaks fastest.
Sustained release (Wellbutrin SR): taken twice daily, intermediate peak.
Extended release (Wellbutrin XL): taken once daily, slowest peak and slightly lower peak concentration than SR.

The XL formulation produces a longer time to peak concentration and a slightly lower peak level, which may translate into slightly better tolerability for some people, particularly regarding insomnia.⁷ In practice, though, prescribers often choose based on dosing convenience (once versus twice daily) and insurance coverage rather than meaningful clinical differences. If you’ve been doing well on SR and someone suggests switching to XL purely for convenience, there’s no reason to expect the drug will work differently.

Typical Dosage

Wellbutrin SR is usually started at 150 mg once daily for the first several days, then increased to 150 mg twice daily. That twice-daily dose of 300 mg per day is the standard target for depression. Each dose should be spaced at least eight hours apart, and the second dose should be taken early enough in the day to avoid worsening insomnia. For smoking cessation, the same 150 mg twice-daily schedule is standard, typically started one to two weeks before the quit date.

The maximum recommended dose of Wellbutrin SR is 400 mg per day, split into two 200 mg doses. Higher doses raise the risk of seizures, which is the main dose-limiting concern with bupropion. The tablets should never be crushed, split, or chewed, because doing so defeats the sustained-release mechanism and dumps the full dose at once.

Common Side Effects

In clinical trials at the recommended 150 mg twice-daily dose, the most frequently reported side effects were insomnia, headache, dry mouth, nausea, and anxiety. Of those, only insomnia and dry mouth occurred at rates significantly higher than placebo.⁸ The headache, nausea, and anxiety seen in trials were partly attributable to nicotine withdrawal itself, since many participants were quitting smoking at the same time.

Insomnia is the side effect most likely to affect your quality of life. It tends to be worst during the first few weeks and often improves as your body adjusts. Taking the second dose no later than mid-afternoon can help. Dry mouth is generally manageable and not a reason most people stop the medication. Some people also report a jittery or “wired” feeling, especially early on, which is consistent with the drug’s activating profile.

Why It Stands Out on Sexual Side Effects

This is where bupropion genuinely separates itself from most antidepressants, and it’s a big reason prescribers reach for it. In a direct comparison study, 86% of bupropion-treated patients reported no adverse sexual effects, compared to just 27% of patients on SSRIs like fluoxetine, paroxetine, and sertraline. Even more striking, 77% of bupropion-treated patients reported at least one aspect of heightened sexual functioning.⁹ A broader review confirmed that bupropion causes significantly less sexual dysfunction than SSRIs and venlafaxine in both short- and longer-term use.¹⁰

For anyone who has tried an SSRI and found sexual side effects intolerable, bupropion is often the first alternative considered. Some clinicians also add bupropion to an SSRI specifically to counteract SSRI-induced sexual dysfunction, though that strategy means managing two medications.

Effects on Weight

Unlike most antidepressants, which tend to cause weight gain over time, bupropion is associated with modest weight loss. A meta-analysis of randomized trials found that bupropion treatment lowered body weight by roughly 3.7 kg (about 8 pounds) compared to placebo.¹¹

Individual trials have shown even larger effects at higher doses and with longer treatment. In a 48-week trial, participants on bupropion SR at 300 mg per day maintained losses of about 7.5% of their starting weight, and those on 400 mg per day lost about 8.6%.¹² In a study of overweight women specifically, bupropion responders who continued treatment for 24 weeks achieved a mean weight loss of nearly 13%, with fat accounting for the vast majority of weight lost and no loss of bone density.¹³

Bupropion is not approved as a standalone weight-loss drug, but it is one of the two active ingredients in Contrave (bupropion plus naltrexone), which is FDA-approved for weight management. The weight-loss effect is worth knowing about because it often tips the decision toward bupropion for patients with depression or smoking dependence who are also concerned about weight gain from medication.

Cardiovascular Considerations

Bupropion has a relatively mild cardiovascular profile compared to older antidepressants like tricyclics, but it is not entirely neutral. In studies of depressed patients with existing heart disease, bupropion did not cause conduction problems, did not worsen ventricular arrhythmias, had low rates of orthostatic hypotension, and did not affect heart rate. However, it caused a rise in supine blood pressure, and about 14% of patients with heart disease discontinued treatment due to adverse effects, including worsening of baseline hypertension in two patients.¹⁴

In outpatient studies, bupropion-treated patients showed small but statistically significant increases in resting diastolic blood pressure of about 6 mm Hg after a week and roughly 7.5 mm Hg after a month.¹⁵ For most people, a bump of that size is clinically insignificant. But if you already have poorly controlled blood pressure, it is worth monitoring, particularly in the first few weeks.

The Seizure Risk

Seizures are the most talked-about serious risk with bupropion, and the fear of them shapes many prescribing decisions. The risk is dose-dependent: at 300 mg per day or below, the seizure rate is estimated at roughly 0.1%, comparable to many other antidepressants. At 450 mg per day, the rate rises, and above 450 mg per day, it climbs more steeply. This is why there is a firm ceiling on dosing. Bupropion is contraindicated in people with a seizure disorder, a history of anorexia or bulimia nervosa (because electrolyte disturbances and purging raise seizure susceptibility), or any condition that sharply lowers the seizure threshold. It is also contraindicated for anyone taking a monoamine oxidase inhibitor (MAOI), which can produce dangerous interactions.

For people without pre-existing seizure risk factors, the risk at standard doses is low enough that it should not be a deal-breaker. But it does mean that bupropion is one of the few antidepressants where going above the recommended dose can have rapid, serious consequences, and where certain medical histories genuinely rule the drug out.

The Black Box Warning on Suicidality

Like all antidepressants, Wellbutrin SR carries the FDA’s black box warning about increased risk of suicidal thoughts and behavior in children, adolescents, and young adults during early treatment. In 2004, the FDA directed manufacturers to add this warning for patients under 18, and in 2007 it was expanded to include young adults aged 18 through 24.¹⁶ The warning applies to the first weeks of treatment and dose changes. In adults over 24, antidepressants appear to reduce suicidal thinking, and in those over 65, the protective effect is strongest. Close monitoring early in treatment is standard practice regardless of the patient’s age.

Drug Interactions Worth Knowing About

Bupropion is a potent inhibitor of the liver enzyme CYP2D6, which matters because a large number of common medications are processed by that same enzyme. In one study, about half of participants who took bupropion were converted from normal CYP2D6 metabolizers to the equivalent of poor metabolizers, meaning their bodies could no longer break down CYP2D6-dependent drugs at a normal rate.¹⁷ Bupropion’s metabolites actually contribute more to this enzyme-blocking effect than the parent drug itself.¹⁸

In practical terms, this means bupropion can raise blood levels of medications you may be taking alongside it. Common CYP2D6 substrates include certain beta-blockers (metoprolol), some antipsychotics, certain pain medications, and tamoxifen. The tamoxifen interaction is especially important: tamoxifen is a prodrug that requires CYP2D6 to become active, so bupropion can reduce its cancer-fighting effectiveness. If you are taking any other medications, your prescriber should check for CYP2D6 interactions before starting bupropion.

What Happens When You Stop

Bupropion is generally considered to have a milder discontinuation profile than SSRIs and SNRIs, which are well known for causing “brain zaps,” dizziness, and flu-like withdrawal symptoms. That said, abrupt discontinuation is not free of consequences. Case reports document irritability, anxiety, insomnia, headache, and generalized aches after sudden cessation.¹⁹ A gradual taper is the standard recommendation, particularly if you have been taking the medication for months or longer.

Special Populations and Kidney Function

Bupropion and its active metabolites are cleared through the kidneys. In people with impaired kidney function, the drug is cleared more slowly, and its metabolites, which are pharmacologically active, can accumulate to higher-than-expected levels. This makes dosing trickier, and current evidence is thin enough that firm dosage recommendations for patients with significant renal impairment cannot be given.²⁰ Liver disease poses similar concerns, since the liver is responsible for metabolizing bupropion into its active forms. Prescribers typically start at lower doses and monitor more closely in either situation.

What Overdose Looks Like

Bupropion overdoses are taken seriously in emergency departments because they carry a real seizure risk and can produce cardiac effects. In a large Canadian case series, about 17% of overdose patients experienced seizures, over half had tachycardia (rapid heart rate), and nearly a quarter showed changes on their ECG. The seizure risk scaled with the amount ingested, with the odds increasing by about 13% for every additional 20 mg per kilogram of body weight consumed. Interestingly, patients who had also taken benzodiazepines had over 60% lower odds of seizures, likely because benzodiazepines raise the seizure threshold.²¹

One tricky feature of bupropion overdose, especially with extended-release formulations, is that seizures can be delayed. A study of bupropion XL overdoses found that seizures can appear well after the initial ingestion, and sometimes without any preceding warning signs like agitation or tremors.²² A separate analysis found that tachycardia and altered mental status on arrival were strongly associated with seizure risk. Patients who presented with tachycardia had nearly seven times the odds of seizing.²³ Extended observation in the emergency department, typically at least 24 hours, is standard after a significant bupropion ingestion.

Misuse and Abuse Potential

Because bupropion acts on dopamine, occasional questions arise about whether it can be abused like a stimulant. The short answer is that the risk exists but is low and qualitatively different from stimulant abuse. A systematic review found that bupropion shares some subjective effects with stimulants but lacks certain key reinforcing properties that drive compulsive use. In real-world settings, misuse occurs but is uncommon, and the unpleasant side effects of taking high doses (particularly seizures and agitation) serve as a natural deterrent.²⁴

Most documented cases of bupropion abuse have involved people with pre-existing substance use disorders, often crushing tablets for intranasal or intravenous use to bypass the sustained-release mechanism and get a rapid hit of dopamine. The consequences of that approach are severe, including seizures, confusion, and psychotic symptoms.²⁵ In correctional facilities, bupropion has occasionally been a drug of misuse for this reason, leading some prisons to restrict its availability. For the typical outpatient taking the medication as prescribed, abuse is not a realistic concern.